Difficulty: Medium
Average Score: 86%
Practice
The following concerning the use of benzodiazepines is not true :
Correct answer
D
Rationale
In pharmacology, benzodiazepines are a class of drugs commonly used for their anxiolytic, sedative, hypnotic, anti-seizure, and muscle relaxant properties. The correct answer to this question is option D) Shorter acting agents are preferred as anxiolytics.
This is because longer-acting benzodiazepines, while effective, are associated with a higher risk of accumulation in the body leading to potential drug interactions, tolerance, dependence, and withdrawal symptoms. Shorter-acting agents are preferred for their more predictable pharmacokinetics, reduced risk of accumulation, and lower potential for drug interactions.
Option A) Abuse is associated with memory loss, is true as benzodiazepine abuse can lead to cognitive impairments including memory loss due to their effects on the central nervous system.
Option B) Toxic dose results in prolonged sleep, is true as overdose of benzodiazepines can lead to excessive sedation, coma, and respiratory depression.
Option C) Respiratory depression is reversed by flumazenil, is false. Flumazenil is a benzodiazepine receptor antagonist that can reverse the sedative effects of benzodiazepines but may not completely reverse respiratory depression, especially in cases of severe overdose.
In an educational context, understanding the pharmacological properties of benzodiazepines is crucial for healthcare professionals to make informed decisions regarding their use, potential risks, and appropriate management of overdose or toxicity. Choosing the right benzodiazepine based on its pharmacokinetic profile and therapeutic indication is essential to optimize patient outcomes while minimizing adverse effects.
This is because longer-acting benzodiazepines, while effective, are associated with a higher risk of accumulation in the body leading to potential drug interactions, tolerance, dependence, and withdrawal symptoms. Shorter-acting agents are preferred for their more predictable pharmacokinetics, reduced risk of accumulation, and lower potential for drug interactions.
Option A) Abuse is associated with memory loss, is true as benzodiazepine abuse can lead to cognitive impairments including memory loss due to their effects on the central nervous system.
Option B) Toxic dose results in prolonged sleep, is true as overdose of benzodiazepines can lead to excessive sedation, coma, and respiratory depression.
Option C) Respiratory depression is reversed by flumazenil, is false. Flumazenil is a benzodiazepine receptor antagonist that can reverse the sedative effects of benzodiazepines but may not completely reverse respiratory depression, especially in cases of severe overdose.
In an educational context, understanding the pharmacological properties of benzodiazepines is crucial for healthcare professionals to make informed decisions regarding their use, potential risks, and appropriate management of overdose or toxicity. Choosing the right benzodiazepine based on its pharmacokinetic profile and therapeutic indication is essential to optimize patient outcomes while minimizing adverse effects.